Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT06508983 Org: User:
Start: 06/14/24 End: 03/31/28 Due: 03/31/29

SG2918 For Advanced Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06167486 Org: User:
Start: 12/26/23 End: 12/28/26 Due: 12/28/27

An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06076291 Org: User:
Start: 09/27/23 End: 12/31/26 Due: 12/31/27

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06144710 Org: User:
Start: 11/10/23 End: 10/24/26 Due: 10/24/27

SG1906 for CLDN18.2-Positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05857332 Org: User:
Start: 05/30/23 End: 08/30/27 Due: 08/30/28

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04684108 Org: User:
Start: 11/04/21 End: 06/30/26 Due: 06/30/27

SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.

Phase: N/A Priority: Normal
NCT ID: NCT05293912 Org: User:
Start: 03/03/23 End: 06/30/23 Due: 06/30/24